Tesofensine Peptide? What It Is, How It Works, and Where Research Stands

Tesofensine is an investigational oral small-molecule drug, not a peptide. It inhibits reuptake of serotonin, norepinephrine, and dopamine to reduce appetite and may modestly raise energy use. In Phase 2 trials, participants lost about 10% of body weight over 24 weeks, but side effects and heart-rate changes occurred. It is not FDA approved.[1]

Is **tesofensine** actually a peptide?

Tesofensine is not a peptide. It is an investigational oral small molecule also known as tesofensine (NS2330), a triple monoamine reuptake inhibitor in the phenyltropane class. A peptide is made of amino acids, while tesofensine is a synthetic compound studied for obesity and earlier for neurologic conditions.[1][2]

Why is tesofensine often mislabeled as a peptide?

Many websites group tesofensine with “peptides” because people interested in metabolic health often search for both. That label is not accurate. Unlike injectable longevity peptides, tesofensine is an oral investigational drug that affects brain chemical signaling.[1][3]

What class of drug is tesofensine?

Tesofensine is described as a serotonin-norepinephrine-dopamine reuptake inhibitor, or SNDRI. It is also called a triple monoamine reuptake inhibitor because it affects three signaling chemicals linked with appetite, reward, sleep, pulse, and blood pressure. Its active metabolite, NS2360, has also been described in clinical pharmacology literature.[2][3]

How does **tesofensine** work in the body?

Tesofensine works by blocking reuptake of serotonin, norepinephrine, and dopamine. In plain language, these brain signaling chemicals may stay active longer. Researchers think this may reduce appetite and modestly increase resting energy expenditure, but the same brain effects can also cause insomnia, dry mouth, anxiety, constipation, or faster heart rate.[1][3][4]

Triple monoamine reuptake inhibition

Serotonin, norepinephrine, and dopamine are sometimes called monoamines. Medicines that affect these systems can change hunger, mood, sleep, heart rate, and blood pressure. This is why tesofensine research must balance weight-loss signals with nervous-system and cardiovascular safety signals.[1][2]

Effects on appetite and energy expenditure

In clinical studies, people assigned to tesofensine had greater weight loss than placebo, and researchers described reduced appetite. Some research also suggests higher resting energy expenditure, but any possible benefit must be weighed with side effects such as nausea, constipation, dry mouth, insomnia, and pulse changes.[1][4]

Hypothalamic GABAergic activity

Animal research suggests tesofensine may affect GABAergic neurons in the lateral hypothalamus, a brain area involved in feeding behavior. This helps explain why the drug is being studied for obesity, but animal findings do not prove safety or effectiveness in people.[3]

What does the **24-week** clinical evidence show for weight loss?

The main human obesity data come from TIPO-1, a Phase 2b trial in adults with obesity. Tesofensine was linked with dose-related weight loss over 24 weeks, but side effects were also more common with higher exposure. The drug is still investigational, so these results do not mean it is approved or broadly safe for use.[1]

TIPO-1 Phase 2b results

In TIPO-1, adults with obesity were assigned to placebo or tesofensine 0.25 mg, 0.5 mg, or 1.0 mg daily for 24 weeks along with diet counseling. The 0.5 mg group lost about 10% more body weight than placebo. Side effects included dry mouth, nausea, constipation, hard stools, diarrhea, insomnia, and increased heart rate. Individual results vary.[1]

TIPO-4 extension data

TIPO-4 was an extension study that followed people after the original trial period. Extension data suggested some weight loss could be maintained with ongoing treatment, but longer exposure also means more time to watch for blood pressure, heart rate, mood, sleep, and gastrointestinal side effects.[10]

Phase 3 status

Tesofensine has been listed in later-stage obesity research, including development history connected with NeuroSearch and Saniona. Phase 3 development means researchers are still testing whether benefits outweigh risks in larger groups. It does not mean the drug is FDA approved.[8]

How does **tesofensine** compare to GLP-1 medications like semaglutide and tirzepatide?

Tesofensine is investigational, while semaglutide and tirzepatide have FDA-approved brand products for chronic weight management in eligible patients. Semaglutide (Wegovy/Ozempic, a GLP-1 receptor agonist; also available as compounded semaglutide through licensed 503A pharmacies when legally appropriate) and tirzepatide (Zepbound/Mounjaro, a GIP/GLP-1 receptor agonist; also available as compounded tirzepatide through licensed 503A pharmacies when legally appropriate) work through gut-hormone pathways, not monoamine reuptake. All can have side effects and contraindications, so a clinician should review risks before any obesity medication is used.[5][6][7]

What is the typical **tesofensine dose** and how is it taken?

There is no FDA-approved tesofensine dose. In TIPO-1, researchers studied oral daily doses of 0.25 mg, 0.5 mg, and 1.0 mg for 24 weeks, but those were research doses, not prescribing instructions. Higher exposure may raise the chance of side effects such as dry mouth, insomnia, constipation, pulse changes, and blood pressure concerns.[1]

Some pharmacology sources report that tesofensine undergoes hepatic metabolism, including CYP3A4 metabolism. That matters because some medicines can affect CYP3A4 activity. Because tesofensine has no FDA label, there is no approved U.S. interaction guide, which is one reason investigational use should stay within controlled research or licensed medical oversight.[2][8]

How fast does **tesofensine** work?

In trials, tesofensine was studied over weeks to months, not as a quick weight-loss product. The main Phase 2b trial measured outcomes over 24 weeks. Some appetite effects may appear earlier, but the same period can also reveal side effects such as nausea, constipation, insomnia, dry mouth, and heart-rate changes.[1]

No medication can target only “belly fat.” Weight changes usually occur across the body and depend on diet, activity, sleep, medical conditions, and genetics. Individual results vary, and tesofensine is not approved for weight loss or body-fat reduction in the United States.[1][8]

What are the **side effects** and safety concerns?

Tesofensine affects brain signaling chemicals, so safety concerns include both common side effects and nervous-system or cardiovascular effects. In studies, the most reported side effects included dry mouth, nausea, constipation, hard stools, diarrhea, and insomnia. Heart-rate increases were also reported, which matters for people with heart disease, high blood pressure, arrhythmias, anxiety, or stimulant use.[1][2]

Common side effects

• Dry mouth[1]
• Nausea[1]
• Constipation or hard stools[1]
• Diarrhea[1]
• Insomnia or sleep changes[1]
• Possible anxiety, restlessness, or mood changes because the drug affects monoamine pathways[1][2]
• Increased heart rate[1]

Cardiovascular considerations

Because tesofensine can affect norepinephrine and dopamine pathways, researchers pay close attention to pulse, blood pressure, and heart rhythm. A weight-loss signal is not enough on its own; an obesity medication also needs an acceptable safety profile for people who may already have cardiometabolic risk.[1][2]

Drug interactions

Tesofensine’s monoamine effects raise concern for interactions with medicines that affect serotonin, norepinephrine, dopamine, heart rate, or blood pressure. These may include some antidepressants, stimulants, migraine medicines, and decongestants. Because it is not approved, there is no FDA label with a complete U.S. interaction list.[1][8]

Does tesofensine cause hair loss?

Hair loss was not a main signal in the key tesofensine obesity trial. Still, weight loss itself can sometimes be linked with temporary shedding, especially with rapid calorie changes, low protein intake, low iron, thyroid disease, or stress. If hair loss happens during any weight-loss treatment, a clinician should look for common medical and nutrition causes.[1][11]

Is **tesofensine** FDA approved, and how can patients access it legally?

Tesofensine is not FDA approved and is not currently legally available for prescription in the United States outside clinical trials. That matters because FDA approval includes review of manufacturing quality, dosing, safety warnings, contraindications, and whether benefits outweigh risks for a specific use.[8][9]

Products sold online as tesofensine “research chemicals,” “not for human use,” or imported capsules are not quality-assured for human consumption. They may have wrong strength, contamination, missing safety information, or legal risks. Avoid using these products without a legitimate clinical-trial pathway or licensed medical oversight.[9]

If you are seeking medical weight-loss care now, a licensed clinician can review FDA-approved options such as semaglutide or tirzepatide products, as well as compounded GLP-1 medications when legally appropriate. 503A compounding pharmacies prepare patient-specific medications under state pharmacy oversight and federal compounding rules, but compounded drugs are not FDA approved. Chia is one telehealth option that offers clinician-reviewed access to compounded GLP-1s and longevity peptides through licensed pharmacy partners when appropriate.[5][6][7][9]

Frequently asked questions about **tesofensine**

Keep reading

GLP-1 Weight Loss

FDA-Approved Weight Loss Drugs: How They Work, Who Qualifies, and What to Expect

GLP-1 Weight Loss

How to Get Weight Loss Injections: A Step-by-Step Guide

Weight Loss

Best Weight Loss Medications: A Patient's Guide to GLP-1s and Other Options